Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$963M |
| 3 |
Wells Fargo
WFC
|
+$647M |
| 4 |
ConocoPhillips
COP
|
+$632M |
| 5 |
UnitedHealth
UNH
|
+$490M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$907M |
| 3 |
KKR & Co
KKR
|
+$906M |
| 4 |
CRH
CRH
|
+$670M |
| 5 |
Meta Platforms (Facebook)
META
|
+$593M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.49% |
| 2 | Technology | 10.44% |
| 3 | Healthcare | 8.01% |
| 4 | Financials | 6.79% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4176
PUT
KE Holdings
BEKE
$19.6B
| $764K | ﹤0.01% |
54,000
-114,100
| -68% | -$1.79M |
|
4177
CALL
Ovintiv
OVV
$18B
| $764K | ﹤0.01% |
16,300
-99,900
| -86% | -$5.03M |
|
|
RSVR
4178
Reservoir Media
RSVR
$643M
| $764K | ﹤0.01% |
+96,684
| New | +$771K |
|
4179
Taysha Gene Therapies
TSHA
$1.94B
| $763K | ﹤0.01% |
340,724
-2,794,593
| -89% | -$8.13M |
|
4180
iShares Russell 3000 ETF
IWV
$20.4B
| $762K | ﹤0.01% |
+2,470
| New | +$737K |
|
|
DDL
4181
Dingdong
DDL
$488M
| $762K | ﹤0.01% |
382,964
+270,101
| +239% | +$452K |
|
4182
SKYX Platforms
SKYX
$165M
| $762K | ﹤0.01% |
+801,742
| New | +$784K |
|
4183
CALL
Freshworks
FRSH
$3.57B
| $761K | ﹤0.01% |
+60,000
| New | +$897K |
|
|
ADAP
4184
DELISTED
Adaptimmune Therapeutics
ADAP
| $760K | ﹤0.01% |
779,615
-45,564
| -6% | -$50K |
|
|
EU
4185
enCore Energy
EU
$270M
| $760K | ﹤0.01% |
192,783
-70,852
| -27% | -$313K |
|
|
BCYC
4186
Bicycle Therapeutics
BCYC
$303M
| $759K | ﹤0.01% |
+37,507
| New | +$847K |
|
4187
Castle Biosciences
CSTL
$1.05B
| $758K | ﹤0.01% |
34,827
-213,726
| -86% | -$4.76M |
|
4188
PUT
InterDigital
IDCC
$8.64B
| $758K | ﹤0.01% |
6,500
| – | – |
|
4189
Fidelity High Dividend ETF
FDVV
$10.4B
| $757K | ﹤0.01% |
+16,192
| New | +$740K |
|
4190
Nuvectis Pharma
NVCT
$822M
| $756K | ﹤0.01% |
119,459
+79,958
| +202% | +$543K |
|
4191
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
| $756K | ﹤0.01% |
+9,680
| New | +$732K |
|
|
CMPS
4192
PUT
Compass Pathways
CMPS
$2.03B
| $755K | ﹤0.01% |
125,000
+78,700
| +170% | +$619K |
|
4193
PUT
BHP
BHP
$245B
| $754K | ﹤0.01% |
13,200
-415,900
| -97% | -$24.2M |
|
4194
CALL
Recursion Pharmaceuticals
RXRX
$1.84B
| $750K | ﹤0.01% |
100,000
+58,700
| +142% | +$512K |
|
4195
Planet Labs
PL
$7.54B
| $749K | ﹤0.01% |
402,731
+75,495
| +23% | +$145K |
|
4196
PUT
Whirlpool
WHR
$2.59B
| $746K | ﹤0.01% |
7,300
-125,500
| -95% | -$12.2M |
|
4197
CALL
Corpay
CPAY
$26.5B
| $746K | ﹤0.01% |
2,800
+2,100
| +300% | +$594K |
|
|
4198
PUT
Corpay
CPAY
$26.5B
| $746K | ﹤0.01% |
2,800
+2,100
| +300% | +$594K |
|
4199
Fossil Group
FOSL
$318M
| $746K | ﹤0.01% |
517,833
+416,045
| +409% | +$473K |
|
4200
iShares MSCI USA Momentum Factor ETF
MTUM
$24.7B
| $742K | ﹤0.01% |
+3,809
| New | +$711K |
|
Similar funds
Israel Englander's Q2 2024 Portfolio in Review
As of Q2 2024, Israel Englander held 6,803 positions worth $216B, down 7.8% from $234B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Israel Englander's Q2 2024 filing shows 661 new, 2,109 increased, 2,549 reduced and 995 closed positions. Its largest new stake was QXO Inc: 2,219,158 shares worth $20.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $963M.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2024 buy was QXO Inc: 2,219,158 shares worth $20.6M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $1.12B increase.
- Israel Englander's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $963M.
- Israel Englander fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $907M.
- Israel Englander's ten largest holdings make up 16% of its $216B portfolio in Q2 2024.
- Israel Englander opened 661 new positions and closed 995 in Q2 2024.
- Israel Englander's portfolio value fell 7.8% quarter-over-quarter to $216B.
Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.